ECG Validation Study
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 141 participants.
Also called NCT05445726
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; single masking; primary purpose diagnostic
- Phase
- Phase 2
- Enrolled
- 141 participants
- Sponsor
- Analog Device, Inc.
- Registry
-
NCT05445726
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05445726. Non-randomized; single masking; primary purpose diagnostic. Start 2022-05-19 (actual); primary completion 2022-09-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ECG Validation Study
- Condition
- Atrial Fibrillation
- Intervention (Device)
- CPM Device
- Lead sponsor
- Analog Device, Inc.
- Collaborator
- Hope Research Institute
Record details
- Record id
cardio:ct-nct05445726- Content hash
170640963711dc2f0c111c780c4177a3892274f52f6cc85f8c453ac6eb128c8b